NAMS
Newamsterdam Pharma Co Nv
NASDAQ · Biotechnology
$34.30
+2.24 (+6.99%)
Performance
1D
—
1W
+8.65%
1M
+4.93%
3M
-14.01%
6M
+33.15%
1Y
+78.09%
YTD
-2.56%
Open$32.78
Previous Close$32.06
Day High$34.74
Day Low$32.15
52W High$42.00
52W Low$14.06
Volume537.1K
Avg Volume577.8K
Market Cap3.89B
P/E Ratio—
EPS$-2.02
SectorBiotechnology
Volume Analysis
0.93x average volume
Technical Indicators
SMA 50
$34.68
Below
SMA 200
$27.87
Above
RSI (14)
60.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
+6.1% upside
Current
$34.30
$34.30
Target
$36.39
$36.39
$23.00
$36.39 avg
$47.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 54.76M | 2.67B | 2.72B |
| Net Income | -290,325,846 | 178.81M | 249.35M |
| Profit Margin | -530.3% | 6.7% | 9.2% |
| EBITDA | -302,549,376 | 313.99M | 355.91M |
| Free Cash Flow | — | 105.97M | 147.67M |
| Rev Growth | — | +5.8% | +24.9% |
| Debt/Equity | — | 0.69 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |